P-value" Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?">

Is the "<i>P</i>-value" Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?

KUŞ T., Aktas G., ÇİÇİN İ.

ONCOLOGIST, cilt.29, sa.3, ss.190-191, 2024 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 29 Sayı: 3
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1093/oncolo/oyad145
  • Dergi Adı: ONCOLOGIST
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.190-191
  • Trakya Üniversitesi Adresli: Evet

Özet

This commentary asks if, when determining the target P-value in a clinical study, it is sufficient to evaluate the study as "negative" or "positive" based on the target P-value alone, or whether this could lead to illusions.